학술논문
전자자료 공정이용 안내
우리 대학 도서관에서 구독·제공하는 모든 전자자료(데이터베이스, 전자저널, 전자책 등)는 국내외 저작권법과 출판사와의 라이선스 계약에 따라 엄격하게 보호를 받고 있습니다.
전자자료의 비정상적 이용은 출판사로부터의 경고, 서비스 차단, 손해배상 청구 등 학교 전체에 심각한 불이익을 초래할 수 있으므로, 아래의 공정이용 지침을 반드시 준수해 주시기 바랍니다.
공정이용 지침
- 전자자료는 개인의 학습·교육·연구 목적의 비영리적 사용에 한하여 이용할 수 있습니다.
- 합리적인 수준의 다운로드 및 출력만 허용됩니다. (일반적으로 동일 PC에서 동일 출판사의 논문을 1일 30건 이하 다운로드할 것을 권장하며, 출판사별 기준에 따라 다를 수 있습니다.)
- 출판사에서 제공한 논문의 URL을 수업 관련 웹사이트에 게재할 수 있으나, 출판사 원문 파일 자체를 복제·배포해서는 안 됩니다.
- 본인의 ID/PW를 타인에게 제공하지 말고, 도용되지 않도록 철저히 관리해 주시기 바랍니다.
불공정 이용 사례
- 전자적·기계적 수단(다운로딩 프로그램, 웹 크롤러, 로봇, 매크로, RPA 등)을 이용한 대량 다운로드
- 동일 컴퓨터 또는 동일 IP에서 단시간 내 다수의 원문을 집중적으로 다운로드하거나, 전권(whole issue) 다운로드
- 저장·출력한 자료를 타인에게 배포하거나 개인 블로그·웹하드 등에 업로드
- 상업적·영리적 목적으로 자료를 전송·복제·활용
- ID/PW를 타인에게 양도하거나 타인 계정을 도용하여 이용
- EndNote, Mendeley 등 서지관리 프로그램의 Find Full Text 기능을 이용한 대량 다운로드
- 출판사 콘텐츠를 생성형 AI 시스템에서 활용하는 행위(업로드, 개발, 학습, 프로그래밍, 개선 또는 강화 등)
위반 시 제재
- 출판사에 의한 해당 IP 또는 기관 전체 접속 차단
- 출판사 배상 요구 시 위반자 개인이 배상 책임 부담
'학술논문'
에서 검색결과 591건 | 목록
1~20
Academic Journal
Blondeaux, Eva ; Sonnenblick, Amir ; Agostinetto, Elisa ; Bas, Raphaëlle ; Kim, Hee J ; Franzoi, Maria A ; Bernstein-Molho, Rinat ; Linn, Sabine ; Kwong, Ava ; Pogoda, Katarzyna ; Balmana, Judith ; Smeets, Ann ; Bajpai, Jyoti ; Moore, Halle C F ; Partridge, Ann H ; Phillips, Kelly-Anne ; Toss, Angela ; Rousset-Jablonski, Christine ; Peccatori, Fedro A ; Renaud, Tiphaine ; Ferrari, Alberta ; Paluch-Shimon, Shani ; Mando, Pablo ; Lee, Jeong E ; Fruscio, Robert ; Cui, Wanda ; Wong, Stephanie M ; Vernieri, Claudio ; Ruddy, Kathryn J ; Dieci, Maria V ; Matikas, Alexios ; Rozenblit, Mariya ; Guven, Deniz C ; Lee, Minna ; Villarreal-Garza, Cynthia ; Hwang, Shelley E ; De Marchis, Laura ; Puglisi, Fabio ; Kemp, Zoe ; Meireles, Pedro A ; Parokonnaya, Anastasia ; Werutsky, Gustavo ; Okano, Maiko ; Azim, Hatem A, Jr ; Mati, Kleida ; Rosenberg, Shoshana ; Gelber, Richard ; Boni, Luca ; Lambertini, Matteo
In The Lancet Oncology June 2025 26(6):759-770
Academic Journal
Kastora, Stavroula L. ; Pantiora, Eirini ; Hong, Yong Hwa ; Veeramani, Meenakshi ; Azim, Hatem A, Jr ; Chakrabarti, Rima ; Geisler, Jürgen ; Knoop, Ann ; Lambertini, Matteo ; Linderholm, Barbro ; Meattini, Icro ; Partridge, Ann H ; Vaz-Luis, Ines ; Vorburger, Denise ; Yongue, Gabriella ; Karakatsanis, Andreas ; Valachis, Antonios
In Cancer Treatment Reviews February 2025 133
Academic Journal
Hickey, Martha ; Basu, Partha ; Sassarini, Jenifer ; Stegmann, Mariken E ; Weiderpass, Elisabete ; Nakawala Chilowa, Karen ; Yip, Cheng-Har ; Partridge, Ann H ; Brennan, Donal J
In The Lancet 9-15 March 2024 403(10430):984-996
Academic Journal
Franzoi, Maria Alice ; Agostinetto, Elisa ; Perachino, Marta ; Del Mastro, Lucia ; de Azambuja, Evandro ; Vaz-Luis, Ines ; Partridge, Ann H ; Lambertini, Matteo
In The Lancet Oncology July 2021 22(7):e303-e313
Academic Journal
Dibble, Kate E; Rosenberg, Shoshana M; Snow, Craig; Kirkner, Gregory J; Tayob, Nabihah; Contreras, Magnolia; Roma, Noel D; DeGraffinreid, Cecilia R; Nolan, Timiya S; Hershman, Dawn L; Naughton, Michelle; Partridge, Ann H
Academic Journal
Lambertini, Matteo ; Di Maio, Massimo ; Poggio, Francesca ; Pagani, Olivia ; Curigliano, Giuseppe ; Mastro, Lucia Del ; Paluch-Shimon, Shani ; Loibl, Sibylle ; Partridge, Ann H ; Azim, Hatem A, Jr ; Peccatori, Fedro A ; Demeestere, Isabelle
In Reproductive BioMedicine Online May 2019 38(5):835-844
Academic Journal
Shinn, Eileen; Zahrieh, David; DeMichele, Angela; Zdenkowski, Nick; Lemieux, Julie; Mao, Jun; Bjelic-Radisic, Vesna; Naughton, Michelle J; Pfeiler, Georg; Gelmon, Karen; Balko, Justin M; Egle, Daniel; Zoppoli, Gabriele; Traina, Tiffany; Jimenez, Miguel Martin; Novoa, Silvia Antolin; Haddad, Tufia; Chan, Arlene; Ring, Alistair; Wolff, Antonio; Symmans, William Fraser; Ponce Lorenzo, Jose; Sabanathan, Dhanusha; Burstein, Hal J; Nowecki, Zbigniew Ireneusz; Pristauz-Telsnigg, Gunda; Brufsky, Adam; Bellet-Ezquerra, Meritxell; Foukakis, Theodoros; Novik, Yelena; Rubovszky, Gabor; Singer, Christian F; Muehlbacher, Karoline; Filho, Otto Metzger; Goulioti, Theodora; Law, Ernest; Partridge, Ann H; Carey, Lisa A; Zoroufy, Alex; Hlauschek, Dominik; Fesl, Christian; Mayer, Erica L; Gnant, Michael
BREAST CANCER RESEARCH AND TREATMENT
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
Instituto de Investigación Biomédica y Sanitaria de Alicante (ISABIAL)
r-ISABIAL. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica y Sanitaria de Alicante
Instituto de Investigación Biomédica y Sanitaria de Alicante (ISABIAL)
Academic Journal
Tolaney, Sara M; DeMichele, Angela; Takano, Toshimi; Rugo, Hope S; Perou, Charles; Lynce, Filipa; Parsons, Heather Anne; Santa-Maria, Cesar Augusto; Rocque, Gabrielle Betty; Yao, Wenliang; Sun, Shawn W; Mocci, Simonetta; Partridge, Ann H; Carey, Lisa A
Future Oncology; 2024, Vol. 20 Issue 31, p2343-2355, 13p
Academic Journal
Wang, Sabrina M; Li, Yan; Nash, Amanda; Ren, Yi; Thomas, Samantha M; Francescatti, Amanda B; Barber, Anne; Lynch, Thomas; Frank, Elizabeth S; Grimm, Lars J; Thompson, Alastair M; Partridge, Ann H; Hyslop, Terry; Hwang, E Shelley; Ryser, Marc D
Academic Journal
Academic Journal
Brantley KD; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. kristen_brantley@dfci.harvard.edu.; Department of Medicine, Harvard School of Medicine, Boston, MA, USA. kristen_brantley@dfci.harvard.edu.; Kirkner GJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Hughes ME; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Yale Cancer Center, New Haven, CT, USA.; Varella L; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Harvard School of Medicine, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Suggs G; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Cunningham OM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Ravikumar S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Snow C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Tolaney SM; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Harvard School of Medicine, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Sammons S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Harvard School of Medicine, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Partridge AH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Harvard School of Medicine, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Lin NU; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Medicine, Harvard School of Medicine, Boston, MA, USA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.
Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE
Academic Journal
Mordenfeld Kozlovsky N; Department of Oncology, Sheba Medical Center, Ramat Gan, Israel.; Partridge AH; Department of Medical Oncology, Program for Young Adults with Breast Cancer, Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA 02115, USA.; Department of Medicine, Harvard Medical School, Boston, MA, USA.; Sella T; Department of Oncology, Sheba Medical Center, Ramat Gan, Israel.
Publisher: Sage Country of Publication: England NLM ID: 101510808 Publication Model: eCollection Cited Medium: Print ISSN: 1758-8340 (Print) Linking ISSN: 17588340 NLM ISO Abbreviation: Ther Adv Med Oncol Subsets: PubMed not MEDLINE
Partridge AH; Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA. Ann_partridge@dfci.harvard.edu.; Brigham and Women's Hospital, Boston, MA, USA. Ann_partridge@dfci.harvard.edu.; Harvard Medical School, Boston, MA, USA. Ann_partridge@dfci.harvard.edu.; Morgans A; Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA.; Brigham and Women's Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Knelson LP; Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA.; Recklitis C; Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA.; Harvard Medical School, Boston, MA, USA.; Boston Children's Hospital, Boston, MA, USA.; Nekhlyudov L; Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA.; Brigham and Women's Hospital, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Chi SN; Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA.; Harvard Medical School, Boston, MA, USA.; Boston Children's Hospital, Boston, MA, USA.; Kenney LB; Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA.; Harvard Medical School, Boston, MA, USA.; Boston Children's Hospital, Boston, MA, USA.; Diller L; Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA.; Harvard Medical School, Boston, MA, USA.; Boston Children's Hospital, Boston, MA, USA.; Vrooman LM; Dana-Farber Cancer Institute, 450 Brookline Avenue, Boston, MA, 02215, USA.; Harvard Medical School, Boston, MA, USA.; Boston Children's Hospital, Boston, MA, USA.
Publisher: Springer Science + Business Media Country of Publication: United States NLM ID: 101307557 Publication Model: Print Cited Medium: Internet ISSN: 1932-2267 (Electronic) Linking ISSN: 19322259 NLM ISO Abbreviation: J Cancer Surviv Subsets: PubMed not MEDLINE; MEDLINE
Academic Journal
Tolaney, Sara M, MD; Tarantino, Paolo, MD; Graham, Noah, MB; Tayob, Nabihah, PhD; Parè, Laia, PhD; Villacampa, Guillermo; Dang, Chau T, Prof; Yardley, Denise A, MD; Moy, Beverly, MD; Marcom, P Kelly, MD; Albain, Kathy S, Prof; Rugo, Hope S, Prof; Ellis, Matthew J, PhD; Shapira, Iuliana, MD; Wolff, Antonio C, Prof; Carey, Lisa A, Prof; Barroso-Sousa, Romualdo, MD; Villagrasa, Patricia, PhD; DeMeo, Michelle, BS; DiLullo, Molly, BS; Zanudo, Jorge Gomez Tejeda, PhD; Weiss, Jakob, BS; Wagle, Nikhil, MD; Partridge, Ann H, Prof; Waks, Adrienne G, MD; Hudis, Clifford A, MD; Krop, Ian E, MD; Burstein, Harold J, Prof; Prat, Aleix, Prof; Winer, Eric P, Prof
The Lancet Oncology. 24(3):273-285
Academic Journal
In Seminars in Oncology 2003 30(6):817-825
Academic Journal
Lee, Guek Eng; Rosenberg, Shoshana M; Mayer, Erica L; Borges, Virginia; Meyer, Meghan E; Schapira, Lidia; Come, Steven E; Partridge, Ann H
Academic Journal
Metzger O; Dana-Farber Cancer Institute, Harvard Medical School, Boston.; Mandrekar S; Alliance Foundation Trials Statistics and Data Center, Mayo Clinic, Rochester, MN.; Goel S; Peter MacCallum Cancer Centre, Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; Gligorov J; Institut Universitaire de Cancérologie, Assistance Publique-Hôpitaux de Paris, Sorbonne Université, Tenon Hospital and INSERM Unité 938, Paris.; Unicancer Breast Group, Paris.; Lim E; Garvan Institute of Medical Research, Sydney.; Ciruelos E; Hospital 12 de Octubre, Madrid.; Loibl S; German Breast Group, Neu-Isenburg, Germany.; Dockter T; Alliance Foundation Trials Statistics and Data Center, Mayo Clinic, Rochester, MN.; Gonzàlez Farré X; Institut Oncològic Dr. Rosell, Hospital General de Catalunya i Quirón Dexeus, Barcelona.; Francis PA; Peter MacCallum Cancer Centre, Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; Lynce F; Dana-Farber Cancer Institute, Harvard Medical School, Boston.; Lanzillotti J; Alliance Foundation Trials, Boston.; DuFrane C; Alliance Foundation Trials, Boston.; Wall A; Alliance Foundation Trials Statistics and Data Center, Mayo Clinic, Rochester, MN.; Strand C; Alliance Foundation Trials Statistics and Data Center, Mayo Clinic, Rochester, MN.; Krop I; Yale School of Medicine, New Haven, CT.; Vaz-Luis I; Cancer Survivorship, INSERM Unité 981, Institut Gustave Roussy, Villejuif, France.; Tripathy D; University of Texas M.D. Anderson Cancer Center, Houston.; Loi S; Peter MacCallum Cancer Centre, Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, VIC, Australia.; Prat A; Clinic Barcelona Comprehensive Cancer Center, Barcelona.; Goetz M; Alliance Foundation Trials Statistics and Data Center, Mayo Clinic, Rochester, MN.; Escrivá-de-Romaní S; Vall d'Hebron Institut of Oncology, Hospital Vall d'Hebron, Barcelona.; Porter D; Auckland District Health Board, Auckland, New Zealand.; Spoenlein J; Kliniken Essen-Mitte, Essen, Germany.; Stover DG; Ohio State University Comprehensive Cancer Center-James Cancer Hospital and Solove Research Institute, Columbus.; Sardesai S; Ohio State University Comprehensive Cancer Center-James Cancer Hospital and Solove Research Institute, Columbus.; Heudel P; Centre Léon Bérard, Lyon, France.; Koehler M; Pfizer, Collegeville, PA.; Huang Bartlett C; Pfizer, New York.; Holynskyj A; Pfizer, New York.; Gopalakrishna P; Pfizer, New York.; Gauthier E; Pfizer, New York.; Delaloge S; Cancer Survivorship, INSERM Unité 981, Institut Gustave Roussy, Villejuif, France.; Miller K; Indiana University School of Medicine, Indianapolis.; Winer EP; Yale School of Medicine, New Haven, CT.; Gianni L; Fondazione Michelangelo Onlus, Milan.; Partridge AH; Dana-Farber Cancer Institute, Harvard Medical School, Boston.; DeMichele A; University of Pennsylvania School of Medicine, Philadelphia.; Carey LA; Lineberger Comprehensive Cancer Center, UNC Health, Chapel Hill, NC.
Publisher: Massachusetts Medical Society Country of Publication: United States NLM ID: 0255562 Publication Model: Print Cited Medium: Internet ISSN: 1533-4406 (Electronic) Linking ISSN: 00284793 NLM ISO Abbreviation: N Engl J Med Subsets: MEDLINE
Academic Journal
Loren AW; Perelman School of Medicine of the University of Pennsylvania, Philadelphia, PA.; Lacchetti C; American Society of Clinical Oncology, Alexandria, VA.; Amant F; University Hospitals Leuven, Leuven, Belgium.; Cardonick EH; Cooper University Health Care, Camden, NJ.; Carey LA; University of North Carolina, Chapel Hill, NC.; Christian N; University of Colorado, Denver, CO.; Clark C; Oncology Nursing Society, Pittsburgh, PA.; Dizon DS; Tufts University School of Medicine, Boston, MA.; Henry M; McGill University, Montréal, QC, Canada.; Hudson MH; St Jude Children's Research Hospital, Memphis, TN.; Maués J; GRASP Cancer, Baltimore, MD.; Peterson E; Medical College of Wisconsin, Milwaukee, WI.; Prowell TM; Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD.; Raab R; Messino Cancer Centers, Asheville, NC.; Rogers JE; University of Texas MD Anderson Cancer Center, Houston, TX.; Saeed H; Department of Oncological Sciences, Florida International University, Miami, FL.; Sekeres MA; Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL.; Taylor JS; University of Texas MD Anderson Cancer Center, Houston, TX.; Van Loon K; University of California San Francisco, San Francisco, CA.; Wallace WH; The University of Edinburgh, Edinburgh, Scotland.; Watson KL; Feinberg School of Medicine, Northwestern University, Chicago, IL.; Yadav S; Mayo Clinic, Rochester, MN.; Partridge AH; Dana-Farber Cancer Institute, Boston, MA.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Academic Journal
Valenza C; Harvard Chan School of Public Health, Harvard University, Boston, MA.; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Zheng Y; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA.; Milano M; Division of Medical Senology, European Institute of Oncology, IRCCS, Milan, Italy.; Trapani D; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Giordano E; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Guidi L; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Berton Giachetti PPM; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Boldrini L; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Castellano G; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Katrini J; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Malagutti B; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Antonarelli G; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Conforti F; Division of Medical Oncology, Humanitas Gavazzeni, Bergamo, Italy.; Pagan E; Department of Statistics and Quantitative Methods, University of Milano-Bicocca, Milan, Italy.; Bagnardi V; Department of Statistics and Quantitative Methods, University of Milano-Bicocca, Milan, Italy.; Kirkner GJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Sangalli C; Clinical Trial Office, European Institute of Oncology, IRCCS, Milan, Italy.; Dibble KE; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA.; Colleoni M; Division of Medical Senology, European Institute of Oncology, IRCCS, Milan, Italy.; Regan MM; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA.; Harvard Medical School, Boston, MA.; Munzone E; Division of Medical Senology, European Institute of Oncology, IRCCS, Milan, Italy.; Curigliano G; Division of New Drugs and Early Drug Development for Innovative Therapies, European Institute of Oncology, IRCCS, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy.; Partridge AH; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA.; Harvard Medical School, Boston, MA.
Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Editorial & Opinion
Valenza C; Harvard Medical School, Boston, MA, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Partridge AH; Harvard Medical School, Boston, MA, USA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA; Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.; Regan MM; Harvard Medical School, Boston, MA, USA; Division of Biostatistics, Dana-Farber Cancer Institute, Boston, MA, USA. Electronic address: mregan@jimmy.harvard.edu.
Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9213011 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-3080 (Electronic) Linking ISSN: 09609776 NLM ISO Abbreviation: Breast Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Partridge, Ann H
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어